Bell Potter offers one of Australia’s largest combined retail and institutional distribution networks.
Our wide reaching presence and brand strength gives us the capacity to participate in a wide array of sizeable transactions.
The Bell Potter Corporate Finance team is a market leader in small to mid-cap transactions in growth sectors.
Recent Transactions
FEBRUARY 2025
4D Medical
(ASX:4DX)
$12.5M Placement & SPP
Lead Manager
JANUARY 2025
Mesoblast
(ASX:MSB)
$260.0M Placement
Lead Manager
JANUARY 2025
4Ds Memory
(ASX:4DS)
$8.0M Placement & SPP
Lead Manager
JANUARY 2025
Arrow Minerals
(ASX:AMD)
$7.0M Placement
Joint Lead Manager
DECEMBER 2024
Mesoblast
(ASX:MSB)
$260.0M Placement
Lead Manager
DECEMBER 2024
Anteris Technologies
(ASX:AVR)
$140.2M NASDAQ IPO
Financial Adviser
NOVEMBER 2024
Cuscal
(ASX:CCL)
$337.0M IPO
Joint Lead Manager
NOVEMBER 2024
Vitrafy Life Sciences
(ASX:VFY)
$35.0M IPO
Joint Lead Manager
OCTOBER 2024
IperionX
(ASX:IPX)
$100.0M Placement
Joint Lead Manager
OCTOBER 2024
Capricorn Metals
(ASX:CMM)
$200.0 M Placement
Joint Lead Manager